179 related articles for article (PubMed ID: 21348593)
1. Preventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation.
Chien JW
Expert Rev Respir Med; 2011 Feb; 5(1):127-35. PubMed ID: 21348593
[TBL] [Abstract][Full Text] [Related]
2. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
Sengsayadeth SM; Srivastava S; Jagasia M; Savani BN
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1479-87. PubMed ID: 22449611
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.
Norman BC; Jacobsohn DA; Williams KM; Au BK; Au MA; Lee SJ; Moravec CK; Chien JW
Bone Marrow Transplant; 2011 Oct; 46(10):1369-73. PubMed ID: 21132024
[TBL] [Abstract][Full Text] [Related]
4. How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Williams KM
Blood; 2017 Jan; 129(4):448-455. PubMed ID: 27856461
[TBL] [Abstract][Full Text] [Related]
5. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
Williams KM; Chien JW; Gladwin MT; Pavletic SZ
JAMA; 2009 Jul; 302(3):306-14. PubMed ID: 19602690
[TBL] [Abstract][Full Text] [Related]
6. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
Au BK; Au MA; Chien JW
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1072-8. PubMed ID: 21126596
[TBL] [Abstract][Full Text] [Related]
7. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
Brownback KR; Simpson SQ; Pitts LR; Polineni D; McGuirk JP; Ganguly S; Aljitawi OS; Lin TL; Singh A; Abhyankar S
J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713
[TBL] [Abstract][Full Text] [Related]
8. Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
Bergeron A; Chevret S; Granata A; Chevallier P; Vincent L; Huynh A; Tabrizi R; Labussiere-Wallet H; Bernard M; Chantepie S; Bay JO; Thiebaut-Bertrand A; Thepot S; Contentin N; Fornecker LM; Maillard N; Risso K; Berceanu A; Blaise D; Peffault de La Tour R; Chien JW; Coiteux V; Socié G;
JAMA; 2017 Aug; 318(6):557-566. PubMed ID: 28787506
[TBL] [Abstract][Full Text] [Related]
9. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
[TBL] [Abstract][Full Text] [Related]
10. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
Chien JW; Duncan S; Williams KM; Pavletic SZ
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S106-14. PubMed ID: 19896545
[TBL] [Abstract][Full Text] [Related]
11. Nintedanib in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation.
Tang W; Yu T; Dong T; Liu T; Ji J
Chest; 2020 Sep; 158(3):e89-e91. PubMed ID: 32892892
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.
Del Fante C; Galasso T; Bernasconi P; Scudeller L; Ripamonti F; Perotti C; Meloni F
Bone Marrow Transplant; 2016 May; 51(5):728-31. PubMed ID: 26726939
[No Abstract] [Full Text] [Related]
13. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
[TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux disease and its association with bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplant recipients.
Khalid M; Aljurf M; Saleemi S; Khan MQ; Khan B; Ahmed S; Ibrahim Kel T; Mobeireek A; Al Mohareb F; Chaudhri N
Exp Clin Transplant; 2013 Jun; 11(3):270-3. PubMed ID: 23530912
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplant-related airflow obstruction.
Dudek AZ; Mahaseth H
Curr Opin Oncol; 2006 Mar; 18(2):115-9. PubMed ID: 16462178
[TBL] [Abstract][Full Text] [Related]
16. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.
Bacigalupo A; Chien J; Barisione G; Pavletic S
Semin Hematol; 2012 Jan; 49(1):15-24. PubMed ID: 22221781
[TBL] [Abstract][Full Text] [Related]
17. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
Williams KM; Cheng GS; Pusic I; Jagasia M; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Chien JW; Jacobsohn DA; Pavletic SZ; Martin PJ; Storer BE; Inamoto Y; Chai X; Flowers MED; Lee SJ
Biol Blood Marrow Transplant; 2016 Apr; 22(4):710-716. PubMed ID: 26475726
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
[TBL] [Abstract][Full Text] [Related]
19. Bronchiolitis obliterans syndrome following SARS-CoV-2 infection in an allogeneic hematopoietic stem cell recipient.
Bondeelle L; Giannotti F; Chalandon Y; Le Goff J; Tapparel C; Bergeron A
Am J Transplant; 2023 Jun; 23(6):844-847. PubMed ID: 36972802
[TBL] [Abstract][Full Text] [Related]
20. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.
Yoshihara S; Yanik G; Cooke KR; Mineishi S
Biol Blood Marrow Transplant; 2007 Jul; 13(7):749-59. PubMed ID: 17580252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
